All studies
Pediatric and FamilyPhase II Recruiting
Once-Weekly Investigational Therapy in Adolescents with Type 2 Diabetes
Measuring glycemic control and weight change with an investigational once-weekly injectable in adolescents with inadequately controlled type 2 diabetes.
Time commitment
24 weeks
Compensation
Up to $900
Site
PRIME Trials — Oakbrook Campus
Who may qualify
Adolescents 12–17 with HbA1c 7.5%–10.5% on metformin.
Step 1 of 1
Enroll in this study
Answer a few quick questions below and a study coordinator will call you to confirm eligibility. It takes about a minute and there is no obligation.
Start Enrollment
Once-Weekly Investigational Therapy in Adolescents with Type 2 Diabetes
Step 1 of 4Takes ~1 minute
Enter your ZIP code so we can match you to the nearest site.
Prefer to talk now?
Call or text our team and we will walk you through this study.
